Monzosertib
Monzosertib (AS-0141) is a potent, selective, orally bioavailable inhibitor of CDC7 with an IC50 2.4 nM. It demonstrates antitumor efficacy and can be used in research to study treatments for advanced, metastatic, relapsed, or refractory malignancies, including acute myeloid leukemia (AML) and solid tumors.
Trivial name | AS-0141 |
Catalog Number | E4603 |
Molecular Formula | C21H18N2O |
CAS# | 1402057-88-8 |
SMILES | CN(C)C1=CC=C(C2=CC=CC=C21)C=C3C4=CC=CC=C4NC3=O |
Size | 100mg |
Supplier Page | http://www.selleckchem.com/products/monzosertib.html |
Additional Information | https://file.selleck.cn/downloads/struct/E4603-Monzosertib-chemical-structure.png |